Skip to search formSkip to main contentSkip to account menu

DMP 323

Known as: 2H-1,3-Diazepin-2-one, hexahydro-5,6-dihydroxy-1,3-bis((4-(hydroxymethyl)phenyl)methyl)-4,7-bis(phenylmethyl)-, (4alpha,5alpha,6beta,7beta)-, DMP-323 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

HIV Protease InhibitorsUrea
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
P‐Glycoprotein Effects of Cyclic Urea HIV Protease Inhibitor DMP 323 in Competitional Absorption Studies
Cyclic ureas form a perspective class of non‐peptidic HIV‐1 protease inhibitors with major bioavailability problems. Low… 
2004
2004
CATALYTIC CARBONYLATION OF AMINES AND DIAMINES AS AN ALTERNATIVE TO PHOSGENE DERIVATIVES : APPLICATION TO SYNTHESES OF THE CORE STRUCTURE OF DMP 323 AND DMP 450 AND OTHER FUNCTIONALIZED
  • 2004
  • Corpus ID: 30721102
of Dissertation Presented to the Graduate School of the University of Florida in Partial Fulfillment of the Requirements for the… 
1994
1994
Pharmacokinetics of HIV protease inhibitor DMP 323 in rats and dogs.
DMP 323 is a symmetrically substituted cyclic urea compound with demonstrated activity against human immunodeficiency virus (HIV… 
1994
1994
Potency and selectivity of inhibition of human immunodeficiency virus protease by a small nonpeptide cyclic urea, DMP 323
DMP 323 is a potent inhibitor of the protease of human immunodeficiency virus (HIV), with antiviral activity against both HIV… 
1994
1994
DMP 323, a nonpeptide cyclic urea inhibitor of human immunodeficiency virus (HIV) protease, specifically and persistently blocks intracellular processing of HIV gag polyprotein
DMP 323, a C-2-symmetrical cyclic urea, is representative of a new class of inhibitors of human immunodeficiency virus protease… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)